Construction and validation of a prognostic nomogram model for SCLC patients in Shandong Province, China

Author:

Song Ziqian1,Ma Hengmin1,Sun Hao1,Li Qiuxia2,Liu Yan2,Xie Jing3,Feng Yukun1,Shang Yuwang1,Ma Kena1,Zhang Nan1,Wang Jialin1

Affiliation:

1. Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences

2. Weifang Medical University

3. Shandong University

Abstract

Abstract Background: The prognosis of patients with small cell lung cancer (SCLC) is poor. We aim to figure out the survival rate of SCLC and construct a nomogram survival prediction for SCLC patients in Shandong. Methods: We collected the clinical data of 2219 SCLC patients in various tumor hospitals and general hospitals in fifteen cities in Shandong province from 2010-2014, and the data were randomly divided into a training set and a validation set according to 7:3. We used univariate and multivariate to determine the independent prognostic factors of SCLC, and developed a prognostic nomogram model based on these factors. The predictive discriminatory and accuracy performance of this model was evaluated by the area under the receiver operator characteristic (ROC) curve (AUC), and calibration curves. Results: The overall 5-year survival rate of Shandong SCLC patients was 14.27% with the median survival time being 15.77 months. Multivariate analysis showed that region, sex, age, year of diagnosis, TNM stage (assigned according to the AJCC 8th edition), and treatment type (surgery, chemotherapy, and radiotherapy) were independent prognostic factors and were included in the prognostic nomogram model. The AUC of the training set was 0.724, 0.710, and 0.704 for 1-year, 3-year, and 5-year; the AUC of the validation set was 0.678, 0.670, and 0.683 for 1-year, 3-year, and 5-year. The calibration curves of the prediction are consistent with the ideal curve. Conclusion: We construct a nomogram prognostic model to predict SCLC prognosis with certain discrimination which can provide both clinicians and patients with an effective tool for predicting outcomes and guiding treatment decisions.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3